Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
Job Opportunity In Berlin With Global AMR R&D Hub!
Dear All, The Global AMR R&D Hub is looking for Head of the Global AMR R&D Hub Secretariat! The position would be ...
Read More >
Antibiotic supply chains: Challenges & Opportunities
Dear All, In a report entitled Understanding the Antibiotic Manufacturing Ecosystem: A view of global supply chains, pressure points, and implications ...
Read More >
NIAID BAA To Support In Vitro Diagnostic Product Development
Dear All, Excitingly, NIAID has released a new BAA (Broad Agency Announcement) entitled “Diagnostics Pre-Clinical Services Program.” Similar to the prior ...
Read More >
UK Pull (“Netflix-like”) pilot: STEDI-based QALY value of new antibiotics implies societal value > 10m GBP/year!
Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter), We’ve written before about the UK’s “Netflix” pilot antibiotic ...
Read More >
ICARS seeks Executive Director
Dear All, An interesting job listing for you today! The International Centre for Antimicrobial Resistance Solutions (ICARS) is looking for an ...
Read More >
Future Leaders Against AMR – Fireside Chat with Founder!
Dear All, As some of you may have seen on Twitter, the Future Leaders Against AMR have been busy! I ...
Read More >
Pull mechanisms: Private capital can multiply Subscription (Netflix) and TEV models!
Dear All: Three recent papers bring together an instructive perspective on Pull incentives for the #FireExtinguishersOfMedicine. The first two papers ...
Read More >
Comment on US 2023-2026 National Health Security Strategy
Dear All, The US Office of the Assistant Secretary for Preparedness & Response (ASPR) is looking for comments on the 2023-2026 National Health ...
Read More >
Implementation Handbook on National Action Plans from WHO
Dear All, Continuing on the theme of helping countries develop their own national action plans, WHO released the “WHO implementation ...
Read More >
Discussing Details of ATMF’s 2021 AMR Benchmark Report!
Dear All, As you may remember, last fall I wrote a newsletter about ATMF’s 3rd update to the AMR Benchmark series. ...
Read More >
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Dear All (wonkish alert: coffee up, settle in, and read the reports!), As you will recall, WHO’s most current pipeline ...
Read More >
Sign a letter in support of antifungal R&D … in support of PASTEUR!
Dear All: As you know if you are a regular reader of this newsletter, I think that creation of suitable Pull ...
Read More >
RFP: Gender inequality in AMR (with a focus on sub-Saharan Africa)
Dear All, Continuing with the theme of socio-economic inequality and AMR that we discussed in prior newsletters (31 Jan 2022, ...
Read More >
CC4CARB: (free!) rationally designed compound libraries based on your ideas!
Dear All, NIAID and RTI International have recently announced the initiation of CC4CARB Chemistry Center for Combating Antibiotic Resistance). In ...
Read More >
RFP: Climate-Sensitive Infectious Disease Modelling
Dear All, And now for something really different! With the recent GRAM report (20 Jan 2022 newsletter) showing that AMR is ...
Read More >
RFP: Support for creating Antimicrobial Stewardship Centers of Excellence
Dear All, I wrote in a 26 Oct 2021 newsletter about an RFP focused on Antimicrobial Stewardship (AMS) activities to address ...
Read More >
AlphaFold: Highly accurate protein structure prediction for WHO priority pathogens
Dear All, I learned today from our colleagues at WHO that Alphafold has recently added the proteome of nearly all the ...
Read More >
FORWARD Act, PREVENT Act, new NIAID RFP!
Dear All, Our US government colleagues have been busy! Three things back-to-back: First, the FORWARD Act (Finding Orphan-disease Remedies With Antifungal ...
Read More >
PAR Foundation grants: Early career support, prevention of AMR in the elderly
Dear All, The Stockholm-based PAR Foundation (aka, the Foundation to Prevent Antibiotic Resistance) has announced two groups of grant opportunities. First, ...
Read More >
#AMRSOS! GRAM report: “at least 1.27m deaths/year directly attributable to AMR”
17 Sep 2024 update: This is now the first of a 3-part newsletter series! See also part 2 (“R&D Implications: ...
Read More >